An adaptive response to the glycosuria induced by the new SGLT2 inhibitor class of drugs would be expected. What has not been expected, though, is a response that appears paradoxical. A recent study highlights the duality and the net result.
Veronica Hackethal, MD
A paw on the leg, a wet nose in the night—both have helped diabetes patients avoid the consequences of peaks and troughs in blood sugar. More on how the dogs do it, here.
Sodium glucose cotransporter 2 inhibitors act independently of insulin level and so can be used at various stages of type 2 diabetes disease progression. Latest findings, here.
Patients aged 80 years or older were more than twice as likely to visit the ED and nearly 5 times as likely to be hospitalized for insulin-related hypoglycemia than those aged 45 to 64 years.
In a US study, diabetes was shown to significantly increase the odds of having restless legs syndrome and a history of diabetes was the most consistent risk factor linked to the disorder.
New guidelines on gestational diabetes from the American College of Gynecology may be useful for family physicians and others who provide postpartum and primary care for women with GDM.
Could fructosamine and glycated albumin serve as back-up to help confirm a diagnosis of type 2 diabetes made by A1C? Here, some pros and cons of all the current tests.
TENS is shown to be an effective adjunct to medication for many patients with DPN. Will it work for your diabetes patients? Pull it out of the toolbox and find out.
A December 2013 joint consensus statement issued by American and European periodontology societies highlights the role of oral health in glycemic control. But not all parties are on the same page.
Incretin-based therapies have been in use for nearly a decade now, as add-on agents to conventional therapy and as initial treatment for some patients. Here, a quick brush-up on GLP-1 agonists and DPP-4 inhibitors.